Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation

Core Viewpoint - Pacira BioSciences, Inc. is responding to DOMA Perpetual Capital Management LLC's nomination of three director candidates for the 2026 Annual Meeting, emphasizing its commitment to shareholder interests and the progress made under its 5x30 strategy aimed at long-term value creation [1][4]. Group 1: Company Strategy and Performance - The company launched a 5x30 strategy in January 2025, focusing on five key pillars with measurable objectives to enhance performance by 2030 [1]. - In 2025, Pacira repurchased $150 million in common stock, reducing outstanding shares from 47 million to 41 million, indicating a disciplined capital allocation strategy [2]. - Pacira treated 2.5 million patients in 2025, aiming to reach 3 million annually by 2030 [5]. - The year-over-year volume growth for EXPAREL® was 6.2% in 2025, up from 3.6% in 2024, reflecting progress towards double-digit compounded annual growth [5]. - The company achieved record-high GAAP and non-GAAP gross margins of 79% and 81% respectively in 2025, with a goal of improving gross margins by five percentage points over a 2024 baseline of 76% [5][19]. Group 2: Product Development and Pipeline - Pacira advanced two Phase 2 clinical programs: PCRX-201, a gene therapy for osteoarthritis, and PCRX-2002, a long-acting local analgesic for postsurgical pain [5]. - Key milestones for 2026 include an interim analysis from a Phase 3 study of ZILRETTA® in shoulder osteoarthritis and topline results from the iovera registration study for spasticity treatment [5]. - The company expanded its commercial reach through collaborations with J&J MedTech and LG Chem [5]. Group 3: Governance and Shareholder Engagement - The Board's Nominating, Governance and Sustainability Committee will review the director nominees proposed by DOMA, with recommendations to be included in the definitive proxy statement [6]. - The date for the 2026 Annual Meeting has not been announced, and shareholders are not required to take any action at this time [7].